Publications by authors named "Colina Yim"

Claim this Profile
E
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical Trials.
Edo J Dongelmans, Jordan J Feld, André Boonstra, Sylvia M Brakenhoff, David Wong, Colina Yim

Aliment Pharmacol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a nurse practitioner-led post-discharge transitional care program for patients with liver disease: A retrospective cohort study.
Marjan Naghshbandi, Simon Y Huang, Hemant Shah, Colina Yim, Elizabeth Lee

Can Liver J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with knowledge and awareness of Hepatitis B in individuals of Chinese descent: Results from a mass point of care testing and outreach campaign in Toronto, Canada.
Andrew B Mendlowitz, Erin Mandel, Camelia I Capraru, Bettina E Hansen, David Wong, Colina Yim

Can Liver J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial.
Donna M Evon, Hsing-Hua S Lin, Mandana Khalili, Abdus S Wahed, Colina Yim

Dig Dis Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B.
Kin Seng Liem, Heng Chi, Scott Fung, David K Wong, Colina Yim

J Viral Hepat· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America.
Mayur Brahmania, Stephen Liu, Abdus S Wahed, Colina Yim, Bettina E Hansen

Ann Hepatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B.
Donna M Evon, Hsing-Hua S Lin, Robert J Fontana, Mandana Khalili, Colina Yim

GastroHep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey.
Nizar A Mukhtar, Donna M Evon, Colina Yim, Anna S Lok, Nadra Lisha

Dig Dis Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients.
Kin Seng Liem, David K Wong, Scott Fung, Alireza Zahirieh, Colina Yim

J Viral Hepat· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis.
Donna M Evon, Hsing-Hua S Lin, Mandana Khalili, Robert J Fontana, Colina Yim

Aliment Pharmacol Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).
Kin Seng Liem, Scott Fung, David K Wong, Colina Yim, Seham Noureldin

Gut· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B.
Kin Seng Liem, Colina Yim, Thomas D Ying, Wayel R Zanjir, Scott Fung

Liver Int· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.
Suraj A Sharma, Matthew Kowgier, Bettina E Hansen, Willem Pieter Brouwer, Raoel Maan, Colina Yim

J Hepatol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection.
Mahmoud Abu-Amara, Orlando Cerocchi, Gurtej Malhi, Suraj Sharma, Colina Yim

Gut· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health state utilities and quality of life in patients with hepatitis B.
Gloria Woo, George Tomlinson, Colina Yim, Les Lilly, George Therapondos

Can J Gastroenterol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociocultural factors that potentially affect the institution of prevention and treatment strategies for prevention of hepatitis B in Chinese Canadians.
Harry Wu, Colina Yim, Alex Chan, Michael Ho, Jenny Heathcote

Can J Gastroenterol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The depiction of stigmatization in research about hepatitis C.
Barbara L Paterson, Markus Backmund, Geri Hirsch, Colina Yim

Int J Drug Policy· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin.
Morris Sherman, Lawrence Cohen, Mary Anne Cooper, Magdy Elkashab, Victor Feinman, Colina Yim

Can J Gastroenterol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse skin reaction in patient with hepatitis B, treated with two different formulations of pegylated interferon.
Piotr Milkiewicz, Colina Yim, Isabelle Pache, Jenny Heathcote

Can J Gastroenterol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis